BCAB vs IT · $5.9M cap vs P/E 16, rev $6.27B
Bioatla Inc (BCAB) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
BCAB currently screens at market cap $5.9M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the BCAB and IT stock pages for the full models.
Not investment advice.